Drug Profile
Delapril
Alternative Names: Adecut; Alindapril; Cupressin; CV-3317; Delacard; Delaket; Delakete; Delapril hydrochloride; Indalapril; REV 6000ALatest Information Update: 21 Jul 2010
Price :
$50
*
At a glance
- Originator Takeda
- Developer Chiesi; Grunenthal; Paiboon Watana; Takeda; TORREX Pharma
- Class Antihypertensives; Indans
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Heart failure; Hypertension
Most Recent Events
- 23 Oct 2000 Launched for Hypertension in Brazil (PO)
- 13 Oct 2000 Discontinued-II for Heart failure in Japan (PO)
- 13 Oct 2000 Discontinued-III for Hypertension in Denmark (PO)